Hybrid APASL meeting 2024

IF 45.9 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Nature Reviews Gastroenterology &Hepatology Pub Date : 2024-06-03 DOI:10.1038/s41575-024-00949-6

Eleni Kotsiliti

引用次数: 0

Abstract Image

查看原文本刊更多论文

2024 年亚太空间法中心混合会议

2024 年 3 月，Nature Reviews Gastroenterology & Hepatology 亲自出席了在历史名城日本京都举行的第 33 届亚太肝脏研究协会（APASL）年会。在开幕式上，Masao Omata 谈到了消除乙型肝炎病毒（HBV）和丙型肝炎病毒（HCV）以及治愈肝硬化的必要性，Shuichiro Shina（亚太肝脏研究协会 2024 年年会主席）就射频和新一代微波消融治疗肝脏肿瘤向与会者发表了讲话。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Gastroenterology &Hepatology 医学-胃肠肝病学

CiteScore

52.30

自引率

0.60%

发文量

147

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Gastroenterology & Hepatology aims to serve as the leading resource for Reviews and commentaries within the scientific and medical communities it caters to. The journal strives to maintain authority, accessibility, and clarity in its published articles, which are complemented by easily understandable figures, tables, and other display items. Dedicated to providing exceptional service to authors, referees, and readers, the editorial team works diligently to maximize the usefulness and impact of each publication. The journal encompasses a wide range of content types, including Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements, all pertinent to gastroenterologists and hepatologists. With its broad scope, Nature Reviews Gastroenterology & Hepatology ensures that its articles reach a diverse audience, aiming for the widest possible dissemination of valuable information. Nature Reviews Gastroenterology & Hepatology is part of the Nature Reviews portfolio of journals.